Research & Projects

ESCMID Panorama

Antimicrobial resistance (AMR) is jeopardising the treatment of infections worldwide. It curtails our ability to successfully protect patients from complicating infections. A lack of effective antibiotics also severely hampers our ability to take advantage of the progress made with research in other medical fields. This page summarizes the major activities aimed at combatting AMR within the ESCMID network and partner organizations.

 

See all of ESCMID's AMR activities detailed on our ESCMID Initiatives page.

A. van der Zande (Director General RIVM), Z. Jakab (Regional Director WHO Europe), G. Kahlmeter (ESCMID President) sign memorandum for CAESAR project in September 2012

ESGAP – The ESCMID Study Group for Antibiotic Policies has conducted the project New Life for Old Antibiotics, jointly with ESCMID’s PK/PD of Anti-Infectives Study Group (EPASG) , and have presented the results at an ESCMID Conference to this topic resulting in several publications (Link to conference website for all information). A dedicated website set up by these two groups hosts more background information on the same topic.

ESGARS – The ESCMID Study Group for Antimicrobial Resistance Surveillance is currently running the CAESAR project together with WHO-Europe and RIVM (NL) to set up an antimicrobial resistance surveillance system in European countries not formally taking part in EARS-Net.

ESGNI – The ESCMID Study Group for Nosocomial Infections is currently involved in the ECDC project TRICE for training in infection prevention and control to ultimately curb spread of antimicrobial resistance. On the same topic, the group runs an annual training course.

The World Alliance against Antimicrobial Resistance (WAAAR) aims to raise awareness about the urgency and magnitude of the threat of AMR and to promote an international dialogue to assist in effective responses. To this end, WAAAR, gathered experts to develop a “manual” on policy to combat antibiotic resistance. Comprised of healthcare, environmental and animal health experts, the group formulated several propositions which were presented in 2018 in the French National Assembly during an event for World Antibiotic Awareness Week. Below, we share the completed manual along with a letter from WAAAR to help spread the word and fight against AMR.

Letter from WAAAR

AMR Manual

 

ESCMID was partner in "Translational Research on Combating Antimicrobial Resistance" (TROCAR), which was a research project funded by the Seventh Framework Programme of the European Commission (2009-2012). The driving concept of TROCAR was to investigate the fundamentals of the epidemiology of new highly virulent multiresistant strains.

ESCMID was partner in "Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe" (GRACE), which was a network of excellence devoted to tackling the increasing problem of resistance to antibiotics when dealing with lower respiratory tract infections, such as bronchitis or pneumonia. This research project was funded by the Sixth Framework Programme of the European Commission (2006-2011).

This is irrespective of whether initiatives are from ESCMID, its members, other societies,  non-governmental organizations or government authorities. ESCMID is not able to financially support all initiatives, but it will provide a scientific platform for selected efforts and prioritize those initiated within the organization and by its members. You can find a list of some European or international initiatives active in the field of combatting antimicrobial resistance and links to their individual (external) websites on our Additional Initiatives page.